Ciudad de la Habana, Cuba

Alejandro Lopez Requena



 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • C. Habana, CU (2013)
  • Ciudad de la Habana, CU (2014)

Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alejandro Lopez Requena: Innovator in Antibody Technology

Introduction

Alejandro Lopez Requena is a notable inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for therapeutic and diagnostic applications. With two patents to his name, his work focuses on addressing critical health challenges, especially related to tumors and cardiovascular diseases.

Latest Patents

Requena's latest patents include "Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors." This invention revolves around the creation of modified antibodies using DNA recombinant technology derived from specific hybridoma cell lines. The innovative aspect of this patent is the development of chimeric and humanized antibodies that maintain the biological functions of the original murine monoclonal antibodies while reducing immunogenicity. These antibodies are positioned for use in the diagnosis and therapy of various tumors.

His second patent, "Anti sulfatides and anti sulfated proteoglycans antibodies and their use," pertains to the creation of new specific monoclonal antibodies with high affinity for sulfatides and sulfated proteoglycans. This invention offers vital diagnostic and therapeutic tools in tackling pathological processes associated with atherosclerotic plaques. The provided pharmaceutical compositions featuring these antibodies present promising avenues for addressing cardiovascular diseases.

Career Highlights

Throughout his career, Alejandro Lopez Requena has worked with prestigious institutions such as the Centro de Inmunología Molecular (CIM). His presence in such an institution underscores his commitment to advancing medical biotechnology and improving human health through innovative solutions.

Collaborations

Requena has collaborated with notable colleagues in his field, including Cristina Maria Mateo De Acosta Del Rio. Such partnerships have played a crucial role in enriching his research endeavors and have contributed to the success of his inventions.

Conclusion

Alejandro Lopez Requena stands out as a visionary inventor making waves in the biotechnology sector. His patents are not only significant advancements in antibody technology but also represent critical steps toward addressing some of the pressing health issues facing humanity today. With his continued work and innovative spirit, Requena is sure to leave a lasting impact in the world of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…